Leverage Shares -3x Short Moderna (MRNA) ETP Securities: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Leverage Shares -3x Short Moderna (MRNA) ETP Securities (NASDAQ:MRNS) reported Q4 earnings with an EPS of $-0.74, missing estimates by -19.0%. Revenue increased by $28 thousand year-over-year. The company had previously beaten EPS estimates in Q3 2023, leading to a 6.0% share price increase the following day.
March 05, 2024 | 9:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Leverage Shares -3x Short Moderna (MRNA) ETP Securities reported a Q4 EPS of $-0.74, missing estimates by -19.0%, with a slight revenue increase from the previous year.
Missing the earnings estimate by -19.0% is likely to negatively impact investor sentiment in the short term, especially considering the stock's positive reaction to the previous quarter's earnings beat. The slight revenue increase may not be sufficient to offset the negative perception from the earnings miss.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100